Table 2.
Thresholds for cutaneous vasodilatation: absolute Tor and ΔTor
Young | Older | |||
---|---|---|---|---|
Tor (°C) | ΔTor (°C) | Tor (°C) | ΔTor (°C) | |
Control | 36.74 ± 0.10 | 0.41 ± 0.07 | 36.76 ± 0.09 | 0.57 ± 0.06* |
NOS inhibited | 36.89 ± 0.08‡ | 0.56 ± 0.04‡ | 36.94 ± 0.06† | 0.75 ± 0.05*† |
Arginase inhibited | 36.73 ± 0.11 | 0.40 ± 0.06 | 36.69 ± 0.07 | 0.50 ± 0.05 |
l-Arg supplemented | 36.95 ± 0.13 | 0.52 ± 0.05 | 36.70 ± 0.09 | 0.52 ± 0.05 |
Arginase inhibited + | ||||
l-Arg supplemented | 36.75 ± 0.10 | 0.42 ± 0.06 | 36.73 ± 0.09 | 0.54 ± 0.07* |
Values are means ± s.e.m.; Tor, oral temperature; ΔTor, change in oral temperature from baseline; NOS, nitric oxide synthase; l-Arg, l-arginine.
Significant difference versus young subject group (P < 0.05).
Significant difference versus control site within the older subject group (P < 0.05).
Significant difference versus control site within the young subject group (P < 0.05).